Intellia Therapeutics Announces Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Intellia Therapeutics (NTLA) Tops Q2 EPS by 8c, Revenues Beat
August 6, 2020 8:07 AM EDTIntellia Therapeutics (NASDAQ: NTLA) reported Q2 EPS of ($0.61), $0.08 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $16.26 million versus the consensus estimate of $8.54 million.
We are very... More
